Posted by Michael Wonder on 09 Oct 2025
Why the Government must urgently raise the NICE cost effectiveness threshold
7 October 2025 - NICE plays an important role in determining whether new medicines will be funded for NHS patients . It does this by assessing whether a new medicine, or a new use of an existing medicine, is considered a good use of NHS money.
At the heart of the process is NICE’s baseline cost effectiveness threshold. This is the cost the NHS will pay to achieve one year of good health, currently £20,000 – £30,000/QALY gained. It is therefore one of the most influential numbers impacting treatment options and outcomes for NHS patients.
